Advocacy Clinical Trials Pharmaceutical Safety 
Cannabis Law Report
DECEMBER 3, 2021
–(BUSINESS WIRE)– $MRNS #MarinusPharma — Marinus Pharmaceuticals, Inc. Chief Executive Officer of Marinus Pharmaceuticals. “We Chief Executive Officer of Marinus Pharmaceuticals. “We Ganaxolone was generally well-tolerated and no new safety findings emerged in the LGS subgroup. RADNOR, Pa.–(BUSINESS
Veriheal
AUGUST 31, 2020
He was exposed to alternative herbal options during his volunteer work as a Spanish interpreter at migrant clinics, and he became interested in medical cannabis when his mother asked him about CBD oil and cannabis as alternative options for her daily shoulder pain. . School: University of Maryland. The club now has 3,000 members nationwide.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
JUNE 4, 2021
Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Healing Advocacy Fund. Jonathan is the CEO and founder of Gilgamesh Pharmaceuticals. Rick Doblin, Ph.D, in/rickdoblin/ [link].
Cannabis Law Report
NOVEMBER 24, 2021
However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. Framings that more often carried a negative tone were related to poor evidence and safety issues. Full size image.
The Cannigma
DECEMBER 22, 2021
We do participate in clinical trials that are initiated by others, and we will have our own clinical trial using terpene formulations in oil. It has the – you assume safety, at least to a certain level. We have, I think, eight PhDs. We have an excellent set of in-house laboratories.
Expert insights. Personalized for you.
52 
Let's personalize your content